Dubai - United Arab Emirates
+919595453000

Anticancer by Bortrac 2

Bortezomib 2mg

In stock

Description

Bortrac 2 mg Injection (Bortezomib IP) is an anti-cancer medication containing 2 mg of the active salt bortezomib per vial, manufactured by Glenmark Pharmaceuticals. It is primarily used to treat multiple myeloma and mantle cell lymphoma.